Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
13,653 total articles
Peabody Energy (BTU) is an industry-leading coal producer trading at a modest multiple relative to peers and history, with a market cap near $2.76B and EV/EBITDA of 9.2. Balance-sheet metrics are tidy and the stock is technically oversold, presenting a risk/reward setup for a position-sized trade. We lay out an actionable plan: buy at $22.50, stop …
SiTime (SITM) is a niche semiconductor company building MEMS-based timing solutions that are now central to AI datacenter and communications infrastructure. Recent results and the Renesas timing-business deal materially accelerate revenue scale; the stock has pulled back from its highs and presents a tradeable long with defined risk controls. This …
Regeneron trades at a mid-teens earnings multiple while growth is accelerating from Dupixent and a differentiated weight‑loss pipeline. With strong free cash flow, low leverage and attractive technical momentum, a tactical long into earnings and upcoming pipeline readouts looks reasonable. Entry $810, stop $760, target $920 over a mid-term 45 tradi…
McKesson (MCK) combines a defensive distribution franchise with a growing technology and specialty-services runway. At roughly $118.7B market cap and $1,017.71 per share, the stock already reflects some optimism. I see a practical trade: long into a 2027 re-rate driven by AI adoption across Prescription Technology Solutions, expanded specialty serv…
Legend Biotech sits between a blockbuster commercial franchise and persistent profitability pressure. Positive clinical readouts and manufacturing investment support upside, but a June underwritten offering, negative PE, and elevated short activity keep the risk elevated. This trade proposes a measured long with a clear stop and a 180-trading-day h…
Netflix reported double-digit revenue growth and expanding margins, yet the stock has been punished after a lowered ad-revenue guide. The business fundamentals and cash generation argue for a tactical long; the trade below balances upside capture with a defined stop to limit execution risk.
Revvity has quietly converted a high-margin diagnostics consumables business into an annuity that funds investments into data and AI products. With a market cap near $17.7B, healthy free cash flow, and recent organic diagnostics strength, I view RVTY as a mid-term long with defined risk controls while the market prices in AI monetization.
Strategy Inc.'s 10.00% Series A perpetual preferred (STRF) trades at about 1.11x mNAV. With management saying it may sell Bitcoin to fund buybacks and preferred payments, the preferred offers a cleaner yield-and-capital-appreciation profile vs. the company deploying new capital into Bitcoin at a premium. This trade plan targets the $111.99 52-week …
Apple (AAPL) is a buy for disciplined portfolios at current levels thanks to $136.7B in free cash flow, a $5.03T market cap, and steady services and hardware cash generation. Valuation is rich (PE ~39, PB ~46.7, EV/EBITDA ~30), so we recommend a tactical long with strict sizing (3% portfolio) and a mid-term horizon to capture post-product-cycle and…
MSCI reported 12.4% revenue growth and beat Q3 estimates, but the shares are priced for perfection. With a market cap near $44B, P/E ~31, EV/EBITDA ~24 and FCF yield around 3.3%, upside is limited versus the downside to a re-rating if growth or margin tailwinds slow. I outline a mid-term short trade (45 trading days) with an entry at $604.71, a $66…
Rigel is morphing from a small clinical-stage biotech into a commercial biotech with multiple near-term revenue drivers. FDA approval and a global licensing deal for VEPPANU, steady rollouts of TAVALISSE in Latin America, and recent revenue beats make a compelling case for a re-rate. The balance sheet, cash flow and cheap valuation (sub-3x reported…
Workiva is executing on margin expansion and organic growth at scale: record operating margins, accelerating revenue (~20% year-over-year), and $200M+ of free cash flow. The stock is still trading below historical multiples. This trade targets a re-rate to a more normalized SaaS multiple as AI adoption and enterprise spend lift ARR trajectory.
Meta's Q3 beat and early Muse traction (10M North American users) mark a structural shift: advertising strength is being complemented by a first meaningful AI revenue engine. Valuation sits at a reasonable multiple given growth and $41B in free cash flow. This trade idea buys a pullback into strength with a long-term horizon and defined stop.
Tenet Healthcare (THC) is showing clearer margin improvement and cash conversion than many expect. With EV/EBITDA at 6.85, P/E near 9.7, and free cash flow roughly $3.0B, the stock can re-rate if Q3 results on 10/29/2026 confirm accelerating operating leverage. This trade targets a measured long into and after the print with tight risk control.
Teledyne's mix of high-margin sensors, aerospace electronics and engineered systems is hitting a sweet spot: strong defense infrared demand, a record $5.3B funded backlog and improving margin dynamics are supporting revenue upgrades. With a $29.2B market cap, healthy cash flow ($1.14B FCF) and modest leverage (debt/equity 0.19), this is an actionab…
Texas Instruments has reported another set of upside results and is showing signs of a broader recovery in its end markets. With free cash flow of $5.36B, a 2% dividend yield, and management signaling a quieter capex profile, the risk/reward looks favorable for a mid-term long trade. Technicals are mixed but improving; valuation is premium, so posi…
Diageo is positioned to benefit from renewed alcohol demand among younger drinkers and the global ready-to-drink cocktail trend. Technicals and consumption signals support a tactical long with a clear entry, stop and target over a 180 trading-day horizon.
Privia Health (PRVA) has been compounding top-line growth while beginning to show meaningful EBITDA and free cash flow leverage. With a $2.87B market cap, low/no net debt, and improving operating metrics, the stock looks set up for a mid-term swing trade. Entry $22.50, target $27.50, stop $20.50.
UnitedHealth reported Q3 strength with revenue of $113B and an upgraded EPS outlook; improving Optum margins, sizable free cash flow, and ongoing AI-driven efficiency gains support further multiple expansion. Trade plan: enter at $419.00, target $480.00, stop $390.00 over a 180 trading day horizon.
GoGold (GLGDF) trades at $2.70 with a $1.17B market cap, underpinned by producing Parral tailings and the Los Ricos exploration pipeline. If management delivers the expected production ramp into 2028, the stock can re-rate materially. This trade idea sets an entry at $2.70, a $5.40 target and a $2.00 stop for a long-term (180 trading days) position…
Evolution Petroleum (EPM) pays a quarterly $0.12 dividend (12.8% yield at current price). Recent acquisitions, modest leverage and an EV/EBITDA of 7.7 give the company a credible path to sustain payouts into FY2027, even though earnings and free cash flow are pressured. This trade targets capital appreciation to $5.20 while preserving the dividend …
Houlihan Lokey (HLI) is one of the few boutique advisory firms built to benefit from an uptick in distressed situations. With Financial Restructuring as a core segment, solid free cash flow and a reasonable valuation, HLI offers asymmetric upside if defaults and private-credit stress continue. This trade plan outlines an entry at $128.39, a stop at…
Semtech's recent prints and guidance point to a meaningful acceleration in data-center connectivity revenue after a period of digestion. The market is pricing a stretched multiple on slower growth; we think current momentum and share gains in 800G / 1.6T copper and fiber products justify a re-rating. This is a swing trade with a clear entry, stop, …
Kingstone (KINS) is a small, profitable regional P&C insurer trading at a modest multiple. Management’s move toward retaining more risk (less reinsurance) should lift near-term earnings and free cash flow, but also raises reserve and catastrophe exposure. Trade plan presented for a mid-term swing capturing earnings leverage while protecting against…
BlackBerry's QNX division is transitioning from design wins to royalty-bearing production programs. Recent wins (Coretura/Alloy Kore) add meaningful backlog and validate the firm's strategy to capture more software value per vehicle. With improving cash flow, upgraded guidance, and a still-fragile Secure Communications line, this trade seeks to buy…
